Navigation Links
EMPOWERx E-Prescribing Solution Provides Latest Treatment Guidelines for 2008-2009 H1N1 Influenza Virus

-Solution Provides Physicians with CDC Treatment Guidelines at the Point of Care-

TAMPA, Fla., May 1 /PRNewswire/ -- Informed Decisions, LLC, a leading developer of drug information applications and clinical information solutions, announced today that its leading e-prescribing solution EMPOWERx is now providing physicians with the latest treatment guidelines for the H1N1 Influenza Virus as issued by the Centers for Disease Control and Prevention (CDC).

Due to the recent outbreak of H1N1 Influenza Virus Infection, also known as 'Swine Flu,' the CDC has provided additional guidance for certain medications used in the treatment of the condition. Information about these products and their impact has been updated and made available within EMPOWERx.

Trusted by more than 3500 physicians, EMPOWERx grants access to integrated drug information, drug-drug interaction screenings, real-time patient medication histories, up-to-date formulary information, a secure connection to submit scripts, and more. Physicians can have point-of-care access to this clinical drug reference, e-prescribing program and patient care system via wireless and cellular connectivity as well as the online secure EMPOWERx website.

"At Informed Decisions our goal is to arm physicians with the most current information at the point of care facilitating what we call fully informed prescribing. Whether it pertains to an individual's medication history, formulary updates, or medication guidelines for something as serious as the H1N1 Swine Flu, EMPOWERx is there to keep physicians informed and patients safe," said Kathy Mosbaugh, Executive Vice President, Informed Decisions.

About Informed Decisions, LLC

Informed Decisions (, an Elsevier company is based in Tampa, Fla. The company provides a full array of strategic health information technology services to healthcare interests including state governments, commercial insurance payors, pharmaceutical manufacturers and professional healthcare associations. Its parent company, Elsevier (, is a world-leading publisher of scientific, technical and medical information products and services with more than 7,000 employees in over 70 offices across 24 countries.

    For More Information Contact:
    Lizzy Feliciano, MBA,
    Marketing & Communications
    Informed Decisions, LLC.
    (800) 446-3324

SOURCE Informed Decisions, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ICW and Surescripts to Develop E-Prescribing Prototype Project for SHIN-NY
2. CMPMedica Signs an Agreement With MAIDIS for e-prescribing Solutions in Abu Dhabi (UAE)
3. Zix Corporation and Blue Cross Blue Shield of Massachusetts Expand the Industrys Largest e-Prescribing Program
4. Collaborate and Converse on HIMSS E-Prescribing Wiki
5. Study Finds Doctors Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings
6. Zix Corporation to Participate in $29 Million Highmark e-Prescribing/eHealth Initiative
7. MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTrees VTOC(TM) Web-Based Patient Management System
8. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing And The Importance Of New Medicare-Related E-Prescribing Legislation
9. PCMA Statement on Passage of Medicare Bill: E-Prescribing Requirement a Major Victory for Seniors
10. E-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Toward Reality
11. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
Post Your Comments:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: